CURRENT HEADLINES
- Waters Announces FDA 510(k) Clearance Of BD BACTEC FXI Culture System, Enabling Broader Access To Bloodstream Infection Diagnostics
- Zepto Life Technology Receives FDA Breakthrough Device Designation For Targeted Liquid Biopsy Test For Invasive Mold Infections
- SGS Expands Bioanalytical Testing Capabilities In North America With Acquisition Of CMIC, INC.
- Co-Diagnostics And CoSara Advance Ebola PCR Test Development And Co-Dx™ PCR Point-Of-Care Platform Capabilities
- CirrusDx Now Offers Susceptibility Testing For Blujepa® (gepotidacin), A Recently Approved Antibiotic For Urinary Tract Infections
SUPPLIER NEWS
- LabCorp Furthers Leadership In Personalized Medicine In Cancer By Offering Innovative VistaSeq® Hereditary Cancer Panel
- BRCA Share™ To Improve The Detection Of Inherited Risk Of Breast And Ovarian Cancers
- Beckman Coulter Genomics Receives Accreditation From College Of American Pathologists
- Azbil BioVigilant (ABV) Announces Partnership With University Of Tennessee (UT) Pharmacy College
- Leading Vaccine Manufacturer Boosts IT Efficiency And Reduces TCO By 20%
ARCHIVE NEWSLETTER
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?
BUSINESS WIRE PRESS
- American Cancer Society Recommends Guardant Health's Shield Blood Test In Updated Colorectal Cancer Screening Guidelines
- Argonne Launches First Large-Scale AI Inference Service For Open Science
- Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities With New Laboratory In Gothenburg, Sweden
- Valar Labs Receives FDA Breakthrough Device Designation For Vesta Bladder Risk Stratify Dx
- Charles River Laboratories And MEDIPOST Sign Non-Exclusive MOU To Advance GMP Testing Solutions
- Lucent Diagnostics Announces Collaboration With Tempus To Integrate Blood-Based Alzheimer's Biomarker Testing Into Clinical Workflows
DOWNLOAD LIBRARY
| | Download software |
EVENTS CALENDAR
| | Search events |
| | Post events |
| | Stay informed |
Learn more...
ASSOCIATIONS
Looking for an industry association? Search our listings to find the association that fits your specialty.
Browse now...